Today’s Best Market Rumors (6/21/2012) J&J Risperdal Settlement
Updated throughout the day on the 24/7 Wall St. Wire Johnson & Johnson (NYSE: JNJ) is close to a deal with the government for off-label promotion of antipsychotic Risperdal (WSJ) ...Read Full Story »

